JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 21, 2005; DOI: 10.1124/jpet.104.080135


0022-3565/05/3132-790-797$20.00
JPET 313:790-797, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.080135v1
313/2/790    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fusi, F.
Right arrow Articles by Saponara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fusi, F.
Right arrow Articles by Saponara, S.

CARDIOVASCULAR

Mechanism of Myricetin Stimulation of Vascular L-type Ca2+ Current

Fabio Fusi, Giampietro Sgaragli, and Simona Saponara

Dipartimento di Scienze Biomediche, Università degli Studi di Siena, Siena, Italy

An in-depth analysis of the mechanism of the L-type Ca2+ current [ICa(L)] stimulation induced by myricetin was performed in rat tail artery myocytes using the whole-cell patch-clamp method. Myricetin increased ICa(L) in a frequency-, concentration-, and voltage-dependent manner. At holding potentials (Vh) of –50 and –90 mV, the pEC50 values were 4.9 ± 0.1 and 4.2 ± 0.1, respectively; the latter corresponded to the drug-apparent dissociation constant for resting channels, KR, of 67.6 µM. Myricetin shifted the maximum of the current-voltage relationship by 10 mV in the hyperpolarizing direction but did not modify the threshold for ICa(L) or the T-type Ca2+ current. The Ca2+ channel blockers nifedipine, verapamil, and diltiazem antagonized ICa(L) in the presence of myricetin. Myricetin increased the time to peak of ICa(L) in a voltage- and concentration-dependent manner. Washout reverted myricetin effect on both current kinetics and amplitude at Vh of –90 mV while reverting only current kinetics at Vh of –50 mV. At the latter Vh, myricetin shifted the voltage dependence of inactivation and activation curves to more negative potentials by 6.4 and 13.0 mV, respectively, in the mid-potential of the curves. At Vh of –90 mV, myricetin shifted, in a concentration-dependent manner, the voltage dependence of the inactivation curve to more negative potentials with an apparent dissociation constant for inactivated channels (KI) of 13.8 µM. Myricetin induced a frequency- and Vh-dependent block of ICa(L). In conclusion, myricetin behaves as an L-type Ca2+ channel agonist that stabilizes the channel in its inactivated state.


Received for publication November 4, 2004
Accepted January 20, 2005.

Address correspondence to: Dr. Fabio Fusi, Dipartimento di Scienze Biomediche, Università degli Studi di Siena, via A. Moro 2, 53100 Siena, Italy. E-mail: fusif{at}unisi.it







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.